Hanan Munitz

3.2k total citations
109 papers, 2.2k citations indexed

About

Hanan Munitz is a scholar working on Psychiatry and Mental health, Clinical Psychology and Physiology. According to data from OpenAlex, Hanan Munitz has authored 109 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Psychiatry and Mental health, 22 papers in Clinical Psychology and 11 papers in Physiology. Recurrent topics in Hanan Munitz's work include Schizophrenia research and treatment (36 papers), Electroconvulsive Therapy Studies (31 papers) and Bipolar Disorder and Treatment (14 papers). Hanan Munitz is often cited by papers focused on Schizophrenia research and treatment (36 papers), Electroconvulsive Therapy Studies (31 papers) and Bipolar Disorder and Treatment (14 papers). Hanan Munitz collaborates with scholars based in Israel, United States and Switzerland. Hanan Munitz's co-authors include Haggai Hermesh, Arieh Y. Shalev, Abraham Weizman, Dov Aizenberg, H Wijsenbeek, Roni Shiloh, Ilan Modai, Avner Rotman, Pnina Dorfman-Etrog and Tamar Mozes and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and FEBS Letters.

In The Last Decade

Hanan Munitz

107 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanan Munitz Israel 26 1.1k 419 364 360 294 109 2.2k
Andrew Francis United States 27 1.9k 1.7× 459 1.1× 281 0.8× 1.1k 2.9× 262 0.9× 102 3.0k
Richard C. Risser United States 31 2.6k 2.3× 473 1.1× 321 0.9× 676 1.9× 163 0.6× 48 4.2k
Bobbi J. Woolwine United States 33 1.1k 1.0× 193 0.5× 313 0.9× 589 1.6× 431 1.5× 52 6.1k
Nian‐Sheng Tzeng Taiwan 30 956 0.8× 330 0.8× 584 1.6× 269 0.7× 382 1.3× 183 3.3k
Luís Pintor Spain 25 1.2k 1.0× 143 0.3× 391 1.1× 414 1.1× 174 0.6× 114 2.5k
Yekta Dowlati Canada 11 563 0.5× 283 0.7× 268 0.7× 394 1.1× 402 1.4× 15 4.1k
Beatrice Bortolato Brazil 13 1.1k 1.0× 391 0.9× 432 1.2× 286 0.8× 169 0.6× 15 2.7k
Toby Pillinger United Kingdom 23 1.4k 1.2× 200 0.5× 315 0.9× 279 0.8× 426 1.4× 67 3.3k
Martin Birkett United States 20 773 0.7× 225 0.5× 576 1.6× 367 1.0× 147 0.5× 26 2.3k
M. F. Folstein United States 24 805 0.7× 94 0.2× 285 0.8× 223 0.6× 207 0.7× 37 2.1k

Countries citing papers authored by Hanan Munitz

Since Specialization
Citations

This map shows the geographic impact of Hanan Munitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanan Munitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanan Munitz more than expected).

Fields of papers citing papers by Hanan Munitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanan Munitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanan Munitz. The network helps show where Hanan Munitz may publish in the future.

Co-authorship network of co-authors of Hanan Munitz

This figure shows the co-authorship network connecting the top 25 collaborators of Hanan Munitz. A scholar is included among the top collaborators of Hanan Munitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanan Munitz. Hanan Munitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laufer, Neri, et al.. (2023). Effect of implementation of mental health services within primary care on GP detection and treatment of mental disorders in Israel. Israel Journal of Health Policy Research. 12(1). 4–4. 1 indexed citations
2.
Gal, Gilad, Hanan Munitz, & Itzhak Levav. (2017). Double disparities in the health care for people with schizophrenia of an ethnic-national minority. Israel Journal of Health Policy Research. 6(1). 47–47. 5 indexed citations
3.
Laufer, Neri, Nelly Zilber, Daniel Grupper, et al.. (2013). Mental disorders in primary care in Israel: prevalence and risk factors. Social Psychiatry and Psychiatric Epidemiology. 48(10). 1539–1554. 13 indexed citations
4.
Shiloh, Roni, Rafael Stryjer, Haggai Hermesh, et al.. (2009). Association between corneal temperature and mental status of treatment-resistant schizophrenia inpatients. European Neuropsychopharmacology. 19(9). 654–658. 13 indexed citations
5.
Shiloh, Roni, Tammar Kushnir, Ruth Gross‐Isseroff, et al.. (2008). In vivo occipital–frontal temperature-gradient in schizophrenia patients and its possible association with psychopathology: A magnetic resonance spectroscopy study. European Neuropsychopharmacology. 18(8). 557–564. 10 indexed citations
6.
Hammerman, Ariel, Jacob Dreiher, Shmuel Klang, et al.. (2008). Antipsychotics and Diabetes: An Age-Related Association. Annals of Pharmacotherapy. 42(9). 1316–1322. 51 indexed citations
7.
Shiloh, Roni, Avi Valevski, Dov Aizenberg, et al.. (2003). Precautionary measures reduce risk of definite neuroleptic malignant syndrome in newly typical neuroleptic-treated schizophrenia inpatients. International Clinical Psychopharmacology. 18(3). 147–149. 2 indexed citations
8.
Fischel, Tsvi, Dov Aizenberg, Z. Zemishlany, et al.. (2001). Cyproheptadine Versus Propranolol for the Treatment of Acute Neuroleptic-Induced Akathisia: A Comparative Double-Blind Study. Journal of Clinical Psychopharmacology. 21(6). 612–615. 48 indexed citations
9.
Orr, G. F., Hanan Munitz, & Haggai Hermesh. (2001). Low-dose Clozapine for the Treatment of Parkinson's Disease in a Patient with Schizophrenia. Clinical Neuropharmacology. 24(2). 117–119. 10 indexed citations
10.
Dossenbach, Martín, Robert H. Belmaker, Avner Elizur, et al.. (2000). The effectiveness of olanzapine in treatment-refractory schizophrenia when patients are nonresponsive to or unable to tolerate clozapine. Clinical Therapeutics. 22(9). 1021–1034. 39 indexed citations
11.
Munitz, Hanan, Abraham Weizman, L. L. Prilipko, et al.. (2000). Recognition and treatment of depression in primary care settings in 6 different countries: A retrospective file analysis by WHO. The European Journal of Psychiatry. 14(2). 85–94. 5 indexed citations
12.
Gothelf, Doron, Amos Frisch, Hanan Munitz, et al.. (1999). Clinical characteristics of schizophrenia associated with velo-cardio-facial syndrome. Schizophrenia Research. 35(2). 105–112. 72 indexed citations
13.
Manor, Iris, et al.. (1998). Creatine kinase levels in adolescents at early acute psychosis. European Neuropsychopharmacology. 8. S251–S252. 1 indexed citations
14.
Hermesh, Haggai, et al.. (1996). Muscle enzymes and white blood count as risk factors for the neuroleptic malignant syndrome. European Neuropsychopharmacology. 6. S4–119. 1 indexed citations
15.
Mintz, Matti, et al.. (1995). First month of neuroleptic treatment in schizophrenia: Only partial normalization of the late positive components of visual ERP. Biological Psychiatry. 37(6). 402–409. 12 indexed citations
16.
Hermesh, Haggai, et al.. (1992). Electroconvulsive therapy for persistant neuroleptic-induced akathisia and parkinsonism: A case report. Biological Psychiatry. 31(4). 407–411. 11 indexed citations
17.
Hermesh, Haggai, Abraham Weizman, Zvi Laron, & Hanan Munitz. (1989). Thyrotropin, prolactin and growth hormone responses to thyrotropin releasing hormone in obsessive-compulsive disorder. Biological Psychiatry. 25(7). A6–A7. 1 indexed citations
18.
Shalev, Arieh Y., Haggai Hermesh, & Hanan Munitz. (1987). Severe akathisia causing neuroleptic failure: An indication for lithium therapy in schizophrenia?. Acta Psychiatrica Scandinavica. 76(6). 715–718. 5 indexed citations
19.
Kaminer, Yifrah & Hanan Munitz. (1984). Case Report: Psychomotor Status-like Episodes under Haloperidol Treatment. The British Journal of Psychiatry. 145(1). 87–88. 9 indexed citations
20.
Kaminer, Yifrah, Hanan Munitz, & H Wijsenbeek. (1982). Trihexyphenidyl (Artane) Abuse: Euphoriant and Anxiolytic. The British Journal of Psychiatry. 140(5). 473–474. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew Francis Breakdown of academic impact, for papers by Richard C. Risser Breakdown of academic impact, for papers by Bobbi J. Woolwine Breakdown of academic impact, for papers by Nian‐Sheng Tzeng Breakdown of academic impact, for papers by Luís Pintor Breakdown of academic impact, for papers by Yekta Dowlati Breakdown of academic impact, for papers by Beatrice Bortolato Breakdown of academic impact, for papers by Toby Pillinger Breakdown of academic impact, for papers by Martin Birkett Breakdown of academic impact, for papers by M. F. Folstein
Rankless by CCL
2026